ArticleNature communications2026
A self-supervised electrocardiogram foundation model for empowering cardiovascular disease prediction and genetic factor discovery.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Echocardiographic Phenomapping in HFpEF: From Imaging Biomarkers to Precision Cardiovascular Medicine.Echocardiography (Mount Kisco, N.Y.) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Electrocardiogram (ECG) has been widely used in the diagnosis of cardiovascular disease (CVD). Current deep learning methods for CVD prediction using ECG often lack generalizability and interpretability, resulting in limited performance. Here, we have developed a self-supervised Electrocardiogram Large-scale Foundation Model (ECG-LFM) through pre-training over ten million 12-lead ECGs from multiple ECG datasets. To enhance ECG representation, ECG-LFM integrates contrastive learning with masked language modeling in a self-supervised manner, enabling the model to capture both global contextual information and fine-grained patterns within ECG signals. It was fine-tuned to predict eight types of CVDs and achieved an average area under the receiver operating characteristic curve (AUROC) of 0.930 from multiple datasets, which demonstrates improved performance compared to existing methods. The important ECG-LFM derived features (EDFs) are able to represent known CVD biomarkers, indicating the high interpretability of ECG-LFM. Applications of the EDFs in genome-wide association study identified 24 significant single nucleotide polymorphisms (SNPs) (P-value < 5×10
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.